ConductScience.org, home

Paper7948311

Clinical and toxicological aspects of the antineoplastic drug cladribine: a review.

Guchelaar HJ and 2 others. Ann Hematol, 1994. Cited by 24 papers, by iCite.

Cite this record

ConductScience Library. Clinical and toxicological aspects of the antineoplastic drug cladribine: a review. Papers, record 7948311. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7948311

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Clinical and toxicological aspects of the antineoplastic drug cladribine: a review.
PubMed
Journal
Ann Hematol
PubMed
Year
1994
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
24
iCite
Relative citation ratio, by iCite
0.79
iCite
Revised in PubMed
2026-10-10
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Guchelaar HJH J
2Richel DJD J
3Schaafsma MRM R

Source PubMed

Download CSV of authors

Topics4

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CladribineMajor topic
Adenosine Deaminase
Humans
Lymphocytes

References48

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11346577Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA).Blood1992https://conductscience.org/library/papers/1346577PubMed
26256765Deoxycytidine kinase-mediated toxicity of deoxyadenosine analogs toward malignant human lymphoblasts in vitro and toward murine L1210 leukemia in vivo.Proc Natl Acad Sci U S A1980https://conductscience.org/library/papers/6256765PubMed
381046702-Chlorodeoxyadenosine in the treatment of hairy cell leukemia.Cancer Invest1993https://conductscience.org/library/papers/8104670PubMed
41969613Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine.N Engl J Med1990https://conductscience.org/library/papers/1969613PubMed
513556732-Chlorodeoxyadenosine in the treatment of multiple myeloma.Blood1992https://conductscience.org/library/papers/1355673PubMed
61361080New antimetabolites in the treatment of human malignancies.Semin Oncol1992https://conductscience.org/library/papers/1361080PubMed
76585795Antileukemic and immunosuppressive activity of 2-chloro-2'-deoxyadenosine.Proc Natl Acad Sci U S A1984https://conductscience.org/library/papers/6585795PubMed
813468002-Chlorodeoxyadenosine produces a high rate of complete hematologic remission in relapsed acute myeloid leukemia.J Clin Oncol1992https://conductscience.org/library/papers/1346800PubMed
98093300Complete remission of B-cell chronic lymphocytic leukaemia after oral cladribine.Lancet1993https://conductscience.org/library/papers/8093300PubMed
101357107On the bioavailability of oral and subcutaneous 2-chloro-2'-deoxyadenosine in humans: alternative routes of administration.J Clin Oncol1992https://conductscience.org/library/papers/1357107PubMed
11274634952-Chlorodeoxyadenosine Treatment of Refractory Chronic Lymphocytic Leukemia.Leuk Lymphoma1991https://conductscience.org/library/papers/27463495PubMed
12274632042-Chlorodeoxyadenosine (2-CdA): A Potent Chemotherapeutic and Immunosuppressive Nucleoside.Leuk Lymphoma1991https://conductscience.org/library/papers/27463204PubMed
1313465752-Chlorodeoxyadenosine treatment of lymphoid malignancies.Blood1992https://conductscience.org/library/papers/1346575PubMed
1413571062-Chlorodeoxyadenosine: drug development priorities.J Clin Oncol1992https://conductscience.org/library/papers/1357106PubMed
1580940032'-Chlorodeoxyadenosine: evaluation of a novel predominantly lymphocyte selective agent in lymphoid malignancies.Br J Cancer1993https://conductscience.org/library/papers/8094003PubMed
168097653Nucleoside analogs in treatment of chronic lymphocytic leukemia.Leuk Lymphoma1993https://conductscience.org/library/papers/8097653PubMed
178427892Chronic lymphoproliferative disorders: chronic lymphocytic leukemia and hairy-cell leukemia.Curr Opin Oncol1993https://conductscience.org/library/papers/8427892PubMed
181349035The purine analogs--a therapeutic beauty contest.J Clin Oncol1992https://conductscience.org/library/papers/1349035PubMed
197691237Detection of minimal residual disease by immunostaining of bone marrow biopsies after 2-chlorodeoxyadenosine for hairy cell leukemia.Blood1993https://conductscience.org/library/papers/7691237PubMed
2080948882-Chlorodeoxyadenosine for patients with B-cell chronic lymphocytic leukemia resistant to fludarabine.N Engl J Med1993https://conductscience.org/library/papers/8094888PubMed

See all 48 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.

PMIDTitleJournalYearIn PapersSource
41240270Post-marketing safety profile of cladribine in multiple sclerosis: a disproportionality analysis based on the FDA adverse event reporting system.Int J Clin Pharm2026https://conductscience.org/library/papers/41240270PubMed
23390564Cladribine and bendamustine exhibit inhibitory activity in dexamethasone-sensitive and -resistant multiple myeloma cells.Am J Transl Res2013https://conductscience.org/library/papers/23390564PubMed
20127230[Cladribin. Development of an oral formulation for the treatment of multiple sclerosis].Nervenarzt2010https://conductscience.org/library/papers/20127230PubMed
19921304Development of oral cladribine for the treatment of multiple sclerosis.J Neurol2010https://conductscience.org/library/papers/19921304PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
ADA100PubTator's text mininghttps://conductscience.org/library/genes/100

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7948311

GET https://conductscience.org/api/papers/v1/7948311/references?page=2